Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs NuviaRx
CoreAge Rx and NuviaRx both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxNuviaRx
Ranked #230 · Grade C
Best for: A parent weighing a year up front against paying monthly, where the gap is $894 and the condition is disclosed.
Visit NuviaRxThe verdict
CoreAge Rx edges out NuviaRx on the Rx-Readiness Score, 95 to 51 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
NuviaRx is still a genuine option — the annual decision here is unusually large and clearly stated. Semaglutide is $2,579.40 paying monthly against $1,684.95 on the twelve-month plan — a gap of $894. Tirzepatide is $3,119.40 against $2,044.95, a gap of $1,074. The advertised "$140/mo" is the annual tier, and the asterisk says so. It also holds your card rather than charging it, and only bills once a doctor has prescribed. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | NuviaRx |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 51/100 · C |
| Overall rank | #1 | #230 |
| Semaglutide | $99/mo | $214.95/mo month to month |
| Tirzepatide | $149/mo | $259.95/mo month to month |
| Coverage | All 50 states | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
NuviaRx
Ranked #230 · Grade C
What we like
- It places a hold rather than a charge, and bills only after a doctor reviews and prescribes
- The asterisk under its headline price states the annual-plan condition outright
- All eight divisions across both molecules and four tiers recompute exactly
The caveats
- Paying monthly costs 53% more than the advertised figure, on both molecules
- "Clinically proven 15-20% average weight loss" and "6+ inches waist reduction" have no source
- "Trusted by teams at over 1,000 of the world's leading organizations" is template boilerplate, and it renders on the 404 page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NuviaRx against other providers on our shortlist.
Or browse the full comparison hub.